• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

JVI: Interferon-inducible Mx1 protein inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly

tetano

Editor, Senior Moderator
Published ahead of print 26 September 2012, doi: 10.1128/​JVI.01682-12

Interferon-inducible Mx1 protein inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly

Judith Verhelst1,2,
Eef Parthoens1,2,
Bert Schepens1,2,
Walter Fiers1,2 and
Xavier Saelens1,2,#

1Department for Molecular Biomedical Research, VIB, 9052 Ghent, Belgium
2Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium

ABSTRACT

Mx1 is a GTPase that is part of the antiviral response induced by type I and type III interferons in the infected host. It inhibits influenza virus infection by blocking viral transcription and replication, but the molecular mechanism is not known. Polymerase basic protein 2 (PB2) and nucleoprotein (NP) were suggested to be the possible target of Mx1, but a direct interaction between Mx1 and any of the viral proteins has not been reported. We investigated the interplay between Mx1, NP and PB2 to identify the mechanism of Mx1's antiviral activity. We found that Mx1 inhibits the PB2?NP interaction, and the strength of this inhibition correlated with a decrease in viral polymerase activity. Inhibition of the PB2?NP interaction is an active process requiring enzymatically active Mx1. We also demonstrate that Mx1 interacts with the viral proteins NP and PB2, which indicates that Mx1 protein has a direct effect on the viral ribonucleoprotein complex. In a minireplicon system, avian-like NP from swine virus isolates was more sensitive to inhibition by murine Mx1 than NP from human influenza A virus isolates. Likewise, murine Mx1 displaced avian NP from the viral ribonucleoprotein complex more easily than human NP. The stronger resistance of the A/H1N1 pandemic 2009 virus against Mx1 also correlated with reduced inhibition of the PB2?NP interaction. Our findings support a model in which Mx1 interacts with the influenza ribonucleoprotein complex and interferes with its assembly by disturbing the PB2?NP interaction.


http://jvi.asm.org/content/early/2012/09/20/JVI.01682-12.abstract
 
Back
Top Bottom